We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Press Right to Appeal IRB Denials Directly to HHS
Sponsors Press Right to Appeal IRB Denials Directly to HHS
December 14, 2011
Clinical trial sponsors should be allowed to appeal institutional review board (IRB) denials directly to the HHS, stipulate that only one IRB need oversee multi-site studies and standardize the content of trial data submissions, according to comments on a proposed rule.